Overseas Invited Faculty (Conference program)
Alex A. Adjei
Cleveland Clinic's Cancer Institute, USA
JLCS-IASLC Joint Symposium：Perioperative Lung Cancer Treatment: A Medical Oncology Perspective in the United States
November 6 (Thu) 9:00～10:30
Malcolm V. Brock
Johns Hopkins University School of Medicine, USA
Invited Lecture 2：The Hidden Driver of Post-Pandemic Cancer: Nervous System Dysregulation as the Critical Missing Link in Oncology
November 6 (Thu) 11:20～12:10
Meet the Foreign Experts
November 6 (Thu) 14:20～15:50
David P. Carbone
The Ohio State University, USA
Invited Lecture 8：Hope and progress in lung cancer
November 8 (Sat) 13:00～13:50
Meet the Foreign Experts
November 6 (Thu) 14:20～15:50
Joint Session of Early Career Support Cmte. and International Cmte. (Observer)
November 6 (Thu) 15:40～17:20
Pasi A. Jänne
Dana-Farber Cancer Institute, USA
Symposium 11：Current Status of Antibody-Drug Conjugate (ADC) Development in Lung Cancer
November 7 (Fri) 15:10～16:40
English Outstanding Session (Chair)
November 7 (Fri) 16:55～18:25
English Session 1 (Chair)：Driver mutant lung cancer 1
November 7 (Fri) 13:35～14:35
Chang Hyun Kang
Seoul National University College of Medicine, Korea
Invited Lecture 7：Innovations in the Oncologic Surgery for Thymic Malignancies
November 8 (Sat) 10:05～10:55
Karen Kelly
International Association for the Study of Lung Cancer (IASLC), USA
JLCS-IASLC Joint Symposium：Perioperative treatments
November 6 (Thu) 9:00～10:30
Joint Session of Early Career Support Cmte. and International Cmte.：IASLC Initiatives for Developing Young Talent
November 6 (Thu) 15:40～17:20
Hong Kwan Kim
Samsung Medical Center/ Sungkyunkwan University School of Medicine, Korea
JLCS-IASLC Joint Symposium：Perioperative treatments
November 6 (Thu) 9:00～10:30
David Lam
University of Hong Kong, Hong Kong
Invited Lecture 6：Lung screening and biomarkers for early detection and management of lung cancer
November 7 (Fri) 17:45～18:35
Ticiana Leal
Emory University School of Medicine, USA
English Session 3 (Chair)：Driver mutant lung cancer and SCLC
November 7 (Fri) 15:45～16:45
Geoffrey Liu
Princess Margaret Cancer Centre, Canada
English Session 6 (Chair)：IO and Driver mutant lung cancer
November 8 (Sat) 10:40～11:40
Solange Peters
Lausanne University Hospital(CHUV), Switzerland
English Session 5 (Chair)：Trials in Progress and Translatiional Research
November 8 (Sat) 9:35～10:35
Haris Sair
Johns Hopkins University School of Medicine, USA
Invited Lecture 9：AI and fMRI for Patients with Lung Cancer and Brain Lesions
November 8 (Sat) 11:00～11:40
Jacob Sands
Dana-Farber Cancer Institute, USA
Symposium 10：Update for Treatment Strategies for Small Cell Lung Cancer
November 7 (Fri) 8:30～10:00
English Outstanding Session (Chair)
November 7 (Fri) 16:55～18:25
Ross Soo
National University Cancer Institute, Singapore
English Session 2 (Chair)：Translational Research 1
November 7 (Fri) 14:40～15:40
Charles Swanton
Francis Crick Institute, UK
Invited Lecture 1：Lung Cancer Promotion and Prevention: Myeloid mayhem
November 6 (Thu) 16:20～17:10
Meet the Foreign Experts
November 6 (Thu) 14:20～15:50
Joseph A.Treat
Fox Chase Cancer Center, USA
English Session 4 (Chair)：Driver mutant lung cancer 2
November 8 (Sat) 8:30～09:30
Paul Van Schil
Antwerp University Hospital/ University of Antwerp, Belgium
JLCS-IASLC Joint Symposium：Perioperative treatments
November 6 (Thu) 9:00～10:30
Meet the Foregin Experts
November 6 (Thu) 14:20～15:50
Joint Session of Early Career Support Cmte. and International Cmte. (Observer)
November 6 (Thu) 15:40～17:20
Heather Wakelee
Stanford University/ Stanford Cancer Institute, USA
Meet the Foregin Experts
November 6 (Thu) 14:20～15:50
Joint Session of Early Career Support Cmte. and International Cmte. (Observer)
November 6 (Thu) 15:40～17:20
Symposium 7：Frontiers in Perioperative Treatment of Resectable Non-Small Cell Lung Cancer - Optimization of Immune Checkpoint Inhibitors and Future Prospects
November 7 (Fri) 15:15～16:45